These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 21099692)

  • 1. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
    Guay LA; Musoke P; Fleming T; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Ducar C; Deseyve M; Emel L; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Dransfield K; Bray D; Mmiro F; Jackson JB
    Lancet; 1999 Sep; 354(9181):795-802. PubMed ID: 10485720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
    Ciaranello AL; Perez F; Maruva M; Chu J; Engelsmann B; Keatinge J; Walensky RP; Mushavi A; Mugwagwa R; Dabis F; Freedberg KA;
    PLoS One; 2011; 6(6):e20224. PubMed ID: 21655097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
    Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).
    Onyango-Makumbi C; Omer SB; Mubiru M; Moulton LH; Nakabiito C; Musoke P; Mmiro F; Zwerski S; Wigzell H; Falksveden L; Wahren B; Antelman G; Fowler MG; Guay L; Jackson JB
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):399-407. PubMed ID: 21826009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.
    Lehman DA; Chung MH; Mabuka JM; John-Stewart GC; Kiarie J; Kinuthia J; Overbaugh J
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):522-9. PubMed ID: 19502990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
    Leroy V; Ekouevi DK; Becquet R; Viho I; Dequae-Merchadou L; Tonwe-Gold B; Rouet F; Sakarovitch C; Horo A; Timité-Konan M; Rouzioux C; Dabis F;
    PLoS One; 2008 Feb; 3(2):e1645. PubMed ID: 18286200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    Ngemu EK; Khayeka-Wandabwa C; Kweka EJ; Choge JK; Anino E; Oyoo-Okoth E
    BMC Res Notes; 2014 Jan; 7():52. PubMed ID: 24447387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
    Lallemant M; Le Coeur S; Sirirungsi W; Cressey TR; Ngo-Giang-Huong N; Traisathit P; Klinbuayaem V; Sabsanong P; Kanjanavikai P; Jourdain G; Mcintosh K; Koetsawang S;
    AIDS; 2015 Nov; 29(18):2497-507. PubMed ID: 26372485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda.
    McConnell M; Bakaki P; Eure C; Mubiru M; Bagenda D; Downing R; Matovu F; Thigpen MC; Greenberg AE; Fowler MG
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):291-6. PubMed ID: 18167645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.
    Lehman DA; Chung MH; John-Stewart GC; Richardson BA; Kiarie J; Kinuthia J; Overbaugh J
    AIDS; 2008 Jul; 22(12):1475-85. PubMed ID: 18614871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.